cancer

Older adults, Black patients underrepresented in post-marketing studies
RAPS.org
Wed, 04/28/21 - 09:51 pm
cancer
post-marketing studies
FDA
elderly
racial discrimination
Trillium unveils CD47 clinical research priorities as investors await solid tumor data
Fierce Biotech
Wed, 04/28/21 - 10:52 am
Trillium Therapeutics
CD47
solid tumors
oncology
cancer
FDA Advisory Committee to Review Checkpoint Inhibitors Greenlit Under Accelerated Approval
BioSpace
Sun, 04/25/21 - 01:56 pm
FDA
oncology
cancer
accelerated approvals
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
Merck
Keytruda
Astellas innovation awards offer up ideas to ease cancer patients' pandemic burdens
Fierce Pharma
Tue, 04/20/21 - 07:36 pm
Astellas
cancer
innovation
OrbiMed-incubated Theseus unveils $100M to beat cancer drug resistance
MedCity News
Sun, 04/18/21 - 11:38 pm
OrbiMed
Ariad Pharmaceuticals
Theseus Pharmaceuticals
cancer
Boehringer and MD Anderson extend KRAS cancer collaboration
Pharmaforum
Wed, 04/14/21 - 09:39 pm
Boehringer Ingelheim
MD Anderson
KRAS
cancer
AZ aims at Pfizer, GSK with potential new PARP cancer drug
Pharmaforum
Wed, 04/14/21 - 09:28 am
AstraZeneca
PARP inhibitors
Pfizer
GSK
cancer
Lynparza
ASCO-Friends meeting: NCI offers strategies to modernize cancer trials
RAPS.org
Tue, 04/13/21 - 10:07 pm
ASCO
cancer
clinical trials
Lilly gene-targeted drug shows potential for use across cancers
BioPharma Dive
Sun, 04/11/21 - 11:51 pm
Eli Lilly
AAACR
Retevmo
cancer
clinical trials
With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers
MedCity News
Wed, 04/7/21 - 10:38 am
Volastra Therapeutics
cancer metastasis
cancer
R&D
Microsoft
funding
Invitae borrows against the future
EP Vantage
Tue, 04/6/21 - 11:08 pm
Invitae
cancer
liquid biopsy
M&A
Why Surface Oncology Is Flying Higher After Hours Today
Motley Fool
Tue, 03/30/21 - 10:17 pm
Surface Oncology
FDA
cancer
regulatory
Omega Therapeutics adds $126M to move “programmable” drugs closer to the clinic
MedCity News
Tue, 03/30/21 - 11:55 am
Omega Therapeutics
R&D
programmable drugs
cancer
Boehringer’s big cancer reveal draws near
EP Vantage
Mon, 03/29/21 - 10:27 am
Boehringer Ingelheim
AACR
cancer
oncology
KRAS
As Alkermes shines light on early cancer, neuro assets, biotech searches for collabs, strategic ops
Fierce Biotech
Fri, 03/26/21 - 10:47 am
Alkermes
R&D
cancer
immuno-oncology
Asher Bio adds $55M and takes a page from nature for cancer immunotherapy
MedCity News
Tue, 03/23/21 - 10:27 am
Interluekin-2
Asher Bio
cancer
cancer immunotherapy
CAR-M era begins as Carisma doses first patient
Endpoints
Thu, 03/18/21 - 10:56 am
Carisma Therapeutics
clinical trials
cancer
CAR-M
cell therapy
No knockout blow from Rubius
EP Vantage
Tue, 03/16/21 - 12:01 am
Rubius Therapeutics
RTX-240
clinical trials
cancer
Spectrum Pharma Climbs as FDA to Fast-Track Cancer Drug Review
TheStreet.com
Sun, 03/14/21 - 10:58 pm
Spectrum Pharma
FDA
fast track status
cancer
Inovio’s reinvention falls flat
EP Vantage
Tue, 03/2/21 - 10:51 am
Inovio
VGX-3100
cancer vaccines
cancer

Pages